Stay updated on Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T21:53:50.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Removed key study documents and metadata from the record, including PDFs and location/arm information, thereby altering the materials and context available for the long-term extension study.
    Difference
    18%
    Check dated 2026-09-22T22:53:53.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page's underlying platform version was upgraded from v3.6.6 to v3.7.0, representing a software update.
    Difference
    0.0%
    Check dated 2026-09-15T21:35:14.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page’s revision label was updated to v3.6.6, signaling a new revision of the study record.
    Difference
    0.0%
    Check dated 2026-09-01T18:25:10.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the page's version. The change does not modify the study details or display content.
    Difference
    0.0%
    Check dated 2026-08-11T14:53:01.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    A location entry for Zaporizhzhya, Ukraine, 69600 was added and the Zaporizhzhia, Ukraine, 69600 entry was removed to correct the city spelling in the site listings. The page revision was updated from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-28T05:53:56.000Z thumbnail image

Stay in the know with updates to Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.